The Lift Line

“The bus we need to board is the next one, and it has not yet left.”

Why This Editorial Matters for Your Exam

This op-ed in The Hindu of 7 October 2026 is by K. VijayRaghavan, former Principal Scientific Adviser to the Government of India, who chairs Ashoka University’s Science Advisory Council, and Archish Mittal, Vice-President at the investment firm Iron Pillar. One has run India’s science advisory system; the other invests in technology companies. Together they argue that India’s habit of measuring itself against technologies others built decades ago, “catch-up-itis”, is now the bigger risk.

For background, it fits a run of science-policy stories we have covered: the Prime Minister Research Chair scheme and the Anusandhan National Research Foundation (ANRF) in a 5 September deep dive, the pause in selections under the Rs 1 lakh crore RDI Fund in the 30 September roundup, and this week’s Nobel Prizes, the Physics prize for IceCube among them, which are a reminder of how long the road from curiosity to impact can be.

GS Paper 3: Science and technology, developments and their applications; indigenisation of technology and developing new technology. GS Paper 2: Issues relating to education and human resources; government policies and interventions.

Background and Context

The authors’ two definitions

Term What they mean
Science Discovery, curiosity, the effort to explain the universe, and abstract ideas in mathematics
Technology The development of tools that let humans transform the world
Old relationship Separate enterprises; technology followed science at a distance, sometimes by a century
New relationship Over the past 50 years or so, research and application “sewn together at the hip”

India’s research architecture today

Element Detail
ANRF Anusandhan National Research Foundation, set up under the ANRF Act, 2023; replaced the Science and Engineering Research Board (SERB); Governing Board chaired by the Prime Minister
ANRF funding Rs 50,000 crore over 2023-28, of which Rs 14,000 crore is the central-government share
RDI Fund Rs 1 lakh crore over six years, mostly long-term, low-cost loans for private R&D; selections paused in September 2026 for want of funds for a second round
R&D spending India’s gross expenditure on R&D (GERD) is about 0.6 to 0.7 per cent of GDP
General Financial Rules The Finance Ministry’s rules governing how public money is spent and procured; they bind publicly funded labs and institutes
Clinical trials Regulated under the New Drugs and Clinical Trials Rules, 2019, by the CDSCO

The Analysis

1. The value and the danger of catching up. People fret about the “buses India has missed”: aircraft, advanced weapons, new materials and biotechnology. The authors grant the value of this introspection: it forces the question of whether India’s systems can be streamlined. Catching up is not bad in itself; “much of the world’s industrial history is a history of catching up”. The danger is that it becomes a habit. If ambition is always defined by what someone else has done, India will always arrive late, pay for licences and know-how, and build on foundations laid elsewhere, and those costs recur with every new technological wave.

2. Science and technology have fused. The authors’ central claim is about a “tectonic change”. For most of history, technology followed science at a distance. Now, the distance and time from curiosity to application are short. Two examples:

Curiosity Application
Studying viruses that infect bacteria Much of our understanding of how genes are regulated
Studying how bacteria defend themselves CRISPR gene-editing technology, “within just a few years”

The implication: investing in fundamental research is now the route to leading, not a luxury. “The bus we need to board is the next one, and it has not yet left.”

3. Fix one: education at scale, and “foundries”. AI tools that democratise access to learning can reach millions of students “poorly served by our moribund institutions”, and bypass those institutions where necessary. But “learning science requires doing science”. The authors call for hundreds of experimental “foundries” in engineering, physics, biology, chemistry and mathematics, places where young people work with real instruments on real problems.

4. Fix two: open the national laboratories. Most national labs are poorly accessible to researchers, students and companies outside their walls. The authors propose that every lab be organised into three zones:

Zone Purpose
Green Open interaction
Amber Collaboration
Red Strategic work

Most of what India’s labs do, they argue, belongs in the green and amber zones. Opening them would benefit both the labs and the universities.

5. Fix three: flexibility, earned by compliance. The authors engage with the trust problem directly. Many say India is a low-trust society and that regulators should trust researchers more. The counter is that trust is low because compliance has been poor, which is why rules are onerous. Their answer: India has many “islands of excellence” in universities, institutes and labs that do comply. These should be freed from the weight of General Financial Rules (GFR) compliance, “a weight few other countries place on their scientists”. Accountability should be measured by outcomes, not by procedure at every step.

6. Fix four: faster, predictable regulation. Approvals for research with biological materials and for clinical trials “remain slow and unpredictable”. Every extra hoop favours those with deep pockets, who can afford the time and cost, and shuts out small and medium-sized institutions. High-quality, speedy regulation is therefore a competitiveness issue.

7. The arithmetic of steady improvement. “None of this is beyond us.” Pockets of excellence already exist; what is missing is “the decision to make those pockets the norm”. The closing calculation: improve 10 per cent a year in every sector and field, and India will be nearly seven times better in 20 years (1.1 to the power of 20 is about 6.7).

Data and Institutions Vault

Prelims-grade facts:

Research institutions:

  • ANRF: established under the ANRF Act, 2023; replaced SERB; Governing Board chaired by the Prime Minister.
  • ANRF funding: Rs 50,000 crore over 2023-28; Rs 14,000 crore from the Centre.
  • RDI Fund: Rs 1 lakh crore over six years, mainly long-term, low-cost loans for private R&D; the Technology Development Board (TDB) is the first agency selecting firms.
  • India’s GERD: about 0.6 to 0.7 per cent of GDP.

Rules and regulators:

  • General Financial Rules (GFR), 2017: issued by the Ministry of Finance (Department of Expenditure).
  • New Drugs and Clinical Trials Rules, 2019: regulator is the Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India.
  • Research with genetically engineered organisms is reviewed by the Review Committee on Genetic Manipulation (RCGM) under the Department of Biotechnology.
  • Environmental release is appraised by the Genetic Engineering Appraisal Committee (GEAC) under the Environment Ministry.
  • Both work under rules framed in 1989 under the Environment (Protection) Act, 1986.

Science concepts:

  • CRISPR-Cas9: a gene-editing tool adapted from a bacterial immune defence against viruses; Nobel Prize in Chemistry 2020 to Emmanuelle Charpentier and Jennifer Doudna.
  • Bacteriophage: a virus that infects bacteria.

⚠️ Watch the trap: ANRF replaced SERB, not the Department of Science and Technology, which continues to exist. The GEAC sits under the Environment Ministry, while the RCGM sits under the Department of Biotechnology: do not swap them.

The Debate

For the authors’ view. Catch-up is expensive and permanent: each wave of technology brings new licences and fees. When discovery turns into application within a few years, countries that do the discovery capture the value. India’s talent base, its digital public infrastructure and AI-enabled learning give it a chance to leapfrog rather than follow, provided institutions are allowed to move fast.

The other side. Freeing institutions from financial rules invites misuse, and the authors themselves concede that poor compliance created the rules. Fundamental research pays off over decades and unevenly; with GERD under 1 per cent of GDP, India may need to concentrate scarce money on proven strategic gaps such as jet engines and semiconductors, where catching up is unavoidable. Opening national labs also raises security concerns for dual-use work, which is why the “red zone” matters.

The balanced verdict. Catch-up and frontier research are complements. India will still need to close strategic gaps, but it should not let those gaps define its ambition. The authors’ reforms are incremental and conditional: autonomy for institutions with a compliance record, outcome-based audits rather than none, and zones that protect strategic work. That makes them practical, not utopian.

How to Think About This

Earned autonomy. A recurring theme in governance answers: trust should follow performance. The same logic underlies graded autonomy for higher education institutions and Navratna and Maharatna status for public sector enterprises. Use it for any question on regulatory reform.

Process versus outcome accountability. India’s audit culture checks whether rules were followed, not whether results were delivered. In research, where most experiments fail, procedure-based accountability punishes risk. Link this to GS4 ideas of trust and integrity in public institutions.

From linear to fused innovation. The old “linear model” ran from basic research to applied research to product. The authors describe a fused model where curiosity and application feed each other. This is a useful frame for questions on industry-academia linkage and why India’s patent and product output lags its paper output.

Diagram-in-Words

Argument map

Indian Research Can Shape the World: from catch-up to leading

The authors' argument, from catch-up-itis to the four reforms they propose.

Catch-up-itis always arrive late, pay for licences and know-how, build on foundations laid elsewhere Science and technology have fused over about 50 years, curiosity and application "sewn together at the hip" Bacteriophage studies gave much of our understanding of how genes are regulated Bacterial defence became CRISPR within a few years the evidence So fundamental research is the route to leading not a luxury Foundries hands-on labs; AI-enabled learning Open labs green, amber, red zones Earned freedom from GFR, judged by outcomes Fast regulation biological research, clinical trials four reforms Board the next bus 10% a year is nearly seven times better in 20 years
K. VijayRaghavan and Archish Mittal’s chain of reasoning: catching up as a habit is costly, science and technology have fused, and four institutional reforms let India lead the next wave.
✍️ Mains Answer Framework
Question

The gap between scientific discovery and its application has narrowed sharply. In this light, examine the institutional reforms India needs to move from technological catch-up to research-led leadership. (250 words)

India’s technology debate often lists the “buses it has missed”: aircraft, advanced weapons, new materials and biotechnology. Because the time from discovery to application has shrunk, as CRISPR showed, a research-led strategy can let India lead the next wave instead of paying to catch up with the last.

Limits of catch-up: recurring licence and know-how costs, permanent lateness and dependence on foundations built elsewhere. Reforms needed: (1) Education: use AI to widen access, and create hands-on experimental “foundries” in science and engineering, since learning science requires doing it. (2) National laboratories: open them to universities, students and firms through zoning, green for open work, amber for collaboration and red for strategic programmes. (3) Flexibility: free institutions with a record of compliance from General Financial Rules procedures and judge them by outcomes. (4) Regulation: time-bound, predictable approvals for biological research and clinical trials, which today favour only deep-pocketed players.
Supporting architecture: ANRF under the ANRF Act, 2023, the Rs 1 lakh crore RDI Fund for private R&D, and the need to raise India’s low gross expenditure on R&D. Concerns: misuse of autonomy, security in dual-use research, and urgent strategic gaps that still need targeted catch-up.

Catch-up and frontier research are complements, not rivals; but only institutions built on trust, openness and outcome-based accountability can turn Indian discovery into global technology.

Interview Angle

"Should a developing country like India spend scarce money on curiosity-driven research, or concentrate on catching up in proven technologies?"

Takeaway Box

  • Thesis: stop defining ambition by what others built decades ago; back fundamental research to lead the next wave.
  • Why now: science and technology have fused; CRISPR went from bacterial biology to a tool within a few years.
  • Four fixes: experimental “foundries” and AI-enabled learning; green, amber and red zones for national labs; freedom from GFR compliance for proven institutions, judged by outcomes; fast, predictable approvals for biological research and clinical trials.
  • Context: ANRF (Act of 2023), the Rs 1 lakh crore RDI Fund, GERD at about 0.6 to 0.7 per cent of GDP.
  • Arithmetic: 10 per cent better a year gives nearly seven times in 20 years.

Revision Flowchart

Revision flowchart

Indian research: beyond catch-up

Covers the architecture of Indian research, the authors' argument, the four reforms and numbers, the counter-view, the way forward and the exam angles.

Indian research: lead the next wave, beyond catch-up K. VijayRaghavan and Archish Mittal, The Hindu, 7 October 2026 (GS3 science and technology) Background ANRF ANRF Act, 2023; replaced SERB; Governing Board chaired by the Prime Minister ANRF funding Rs 50,000 crore over 2023-28; Rs 14,000 crore from the Centre RDI Fund Rs 1 lakh crore over six years, mostly low-cost loans for private R&D The argument Catch-up-itis always late; recurring licence and know-how costs Fused science and technology "sewn together at the hip" for about 50 years Example bacterial defence led to CRISPR within a few years Four reforms Foundries hundreds of experimental labs; real instruments, real problems National labs green (open), amber (collaboration), red (strategic) GFR freedom for institutions that comply; accountable for outcomes Regulation faster, predictable approvals; slow rules favour deep pockets The debate counter-view Misuse risk freeing institutions from financial rules invites misuse Urgent gaps jet engines and semiconductors: catching up is unavoidable Security open labs raise dual-use concerns; hence the red zone Way forward Earned autonomy for institutions with a compliance record Open labs to universities and firms; time-bound approvals Arithmetic 10% a year gives nearly seven times in 20 years Exam angle Trap: SERB ANRF replaced SERB, not the Department of Science and Technology Trap: GEAC GEAC is under the Environment Ministry; RCGM under the Department of Biotechnology GERD about 0.6 to 0.7 per cent of GDP Mains reforms to move from catch-up to research-led leadership (250 words)
Revision flowchart: the whole editorial on one screen. Read each band left to right, then cover the facts and recall them from the headings.

Sources: The Hindu, op-ed by K. VijayRaghavan and Archish Mittal, 7 October 2026; background: Ujiyari, 5 September 2026

Key Arguments at a Glance

India should not define its technological ambition by what others built decades ago. Because science and technology are now fused, investment in fundamental research can let India lead in the next wave rather than chase the last one; four reforms would make that possible.

Supporting
  • Catch-up has value, but “catch-up-itis” as a habit means always arriving late, paying for licences and know-how, and building on foundations laid elsewhere, with the costs recurring with every new wave.
  • Over about 50 years, fundamental research and application have been “sewn together at the hip”: studies of viruses that infect bacteria explained gene regulation, and studies of bacterial defence produced CRISPR within a few years.
  • High-quality education at scale, using AI to reach students poorly served by weak institutions, plus hundreds of experimental “foundries” where young people work with real instruments on real problems.
  • National laboratories organised into green (open), amber (collaboration) and red (strategic) zones, with most work belonging in the first two.
  • Proven “islands of excellence” freed from General Financial Rules compliance and held accountable for outcomes, not procedure; faster, predictable approvals for biological research and clinical trials.
Counter

Trust in the research system is low because compliance with rules has been poor, which is why the rules are onerous; loosening financial controls risks misuse of public money. India also has urgent needs in proven technologies such as aero-engines and semiconductors that cannot wait for discovery-led breakthroughs.

Way Forward

Make existing pockets of excellence the norm, step by step: grant earned autonomy to institutions with a compliance record, open national labs to universities and firms, fund hands-on teaching labs, and make biological and clinical-trial approvals time-bound. Steady improvement of 10 per cent a year would make India nearly seven times better in 20 years.

Cite this page: Indian Research Can Shape the World: Beyond Catch-Up — Ujiyari.com | Free UPSC & State PCS Editorial Analysis